...
【24h】

In reply to Drs. Atalar, Caglar, and Ozyar

机译:回复博士。 Atalar,Caglar和Ozyar

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To the Editor: We thank Drs. Atalar, Caglar, and Ozyar for their comments on stereotactic body radiotherapy (SBRT) for a patient with implanted cardiac pacemakers (ICPs). They reported on 1 patient who died 1 month after SBRT with cardiac problems probably unrelated to RT. However, they suggested the establishment of a new guideline for ICPs and implantable cardioverter defibrillators (ICDs) in the era of SBRT and image-guided RT.Our nation-wide survey conducted by the Japan Conformal External Beam Radiotherapy Group (J-CERG) did not include any patients who died after SBRT with malfunction of ICPs and ICDs (1).When a tumor was situated at the same level of the ICP, the computed tomography image of the ICP would be accompanied by severe metallic artifacts. These computed tomography images are not suitable for SBRT planning. Even in such a case, SBRT can be indicated when the position of the subcutaneous ICP can be changed by the patient raising their hands upward.A direct radiation beam through the ICP should be avoided. Also, when a tumor is situated just below the chest wall of the ICP, I would recommend the cardiologists to replace the ICP to an abdominal position.Another Japanese prospective survey of patients with ICP and ICD found 1 case of malfunction in a patient with prostate cancer treated by intensity-modulated RT to the prostate. Even when the ICP is not situated at the same tumor level and no beam passes through the ICP, they recommended precautions during the planning and administration of RT (2).
机译:致编辑:感谢博士。 Atalar,Caglar和Ozyar对植入心脏起搏器(ICPs)的患者的立体定向身体放疗(SBRT)提出了意见。他们报告了1例在SBRT后1个月死亡的患者,其心脏问题可能与RT无关。然而,他们建议在SBRT和影像引导的RT时代为ICP和植入式心脏复律除颤器(ICD)建立新的指南。日本保形外射束放射治疗小组(J-CERG)进行的全国性调查确实不包括任何因ICP和ICD故障而在SBRT后死亡的患者(1)。当肿瘤位于ICP的同一水平时,ICP的计算机断层扫描图像将伴有严重的金属伪影。这些计算机断层扫描图像不适合SBRT规划。即使在这种情况下,当患者抬起双手可以改变皮下ICP的位置时,也可以指示SBRT,应避免通过ICP的直接辐射束。另外,当肿瘤位于ICP的胸壁正下方时,我建议心脏科医生将ICP替换为腹部位置。另一项针对ICP和ICD的日本前瞻性调查发现1例前列腺疾病患者通过调强RT疗法治疗前列腺癌。即使当ICP不在同一肿瘤水平并且没有光束通过ICP时,他们还是建议在RT的计划和管理期间采取预防措施(2)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号